{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:43Z","timestamp":1785545083618,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.gastrohep.2025.502532","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:45:57Z","timestamp":1752680757000},"page":"502532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and healthcare resource utilization in inflammatory bowel disease in Colombia between 2017 and 2021: A retrospective claims database study"],"prefix":"10.1016","volume":"49","author":[{"given":"Fabi\u00e1n","family":"Juliao-Ba\u00f1os","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Parra-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Pacheco-P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeth Tatiana","family":"Acosta Lea\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502532_bib0265","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0275","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0285","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","article-title":"Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review","volume":"18","author":"Kotze","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/apt.15542","article-title":"Inflammatory bowel disease: estimates from the global burden of disease 2017 study","volume":"51","author":"Piovani","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0295","doi-asserted-by":"crossref","first-page":"e24729","DOI":"10.1097\/MD.0000000000024729","article-title":"Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients","volume":"100","author":"Juliao-Ba\u00f1os","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0300","first-page":"3","article-title":"Prevalence of inflammatory bowel disease and related arthritis in Colombia, according to information from the Health and Social Protection Data System","volume":"27","author":"Fern\u00e1ndez-\u00c1vila","year":"2020","journal-title":"Rev Colomb Reum (Engl Ed)"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/0009922806289837","article-title":"Management of inflammatory bowel disease","volume":"46","author":"Grover","year":"2007","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rgmx.2023.03.007","article-title":"Frequency of use and cost of biologic treatment for inflammatory bowel disease and inflammatory bowel disease-associated arthropathy in Colombia in 2019","volume":"89","author":"Fern\u00e1ndez-\u00c1vila","year":"2024","journal-title":"Rev Gastroenterol M\u00e9xico (Engl Ed)"},{"issue":"Suppl. 2","key":"10.1016\/j.gastrohep.2025.502532_bib0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.22516\/25007440.637","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el tratamiento de la enfermedad de Crohn en poblaci\u00f3n adulta","volume":"35","author":"Juliao-Ba\u00f1os","year":"2020","journal-title":"Rev Colomb Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.gastrohep.2025.502532_bib0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.22516\/25007440.636","article-title":"Gu\u00eda para el manejo de colitis ulcerativa en poblaci\u00f3n adulta (actualizaci\u00f3n)","volume":"35","author":"Juliao-Ba\u00f1os","year":"2020","journal-title":"Rev Colomb Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rgmx.2020.05.005","article-title":"Characterization of inflammatory bowel disease in Colombia: results of a national register","volume":"86","author":"Juliao-Ba\u00f1os","year":"2021","journal-title":"Rev Gastroenterol M\u00e9xico (Engl Ed)"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ajg.2010.317","article-title":"5-Aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0335","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.mayocp.2014.08.019","article-title":"Comparative efficacy of biologic therapy in biologic-na\u00efve patients with Crohn disease: a systematic review and network meta-analysis","volume":"89","author":"Singh","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/apt.14852","article-title":"Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease","volume":"48","author":"Singh","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0345","unstructured":"MdSyP social. Comportamiento del aseguramiento [cited 2024 Mar 15]. Available from: https:\/\/www.minsalud.gov.co\/proteccionsocial\/Regimensubsidiado\/Paginas\/coberturas-del-regimen-subsidiado.aspx."},{"key":"10.1016\/j.gastrohep.2025.502532_bib0350","series-title":"Cifras de aseguramiento en salud","year":"2021"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0355","series-title":"International statistical classification of diseases and related health problems, 10th revision","year":"2019"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0360","first-page":"24","article-title":"Enfermedad inflamatoria intestinal","volume":"18","author":"Royero","year":"2003","journal-title":"Rev Colomb Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0365","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.2147\/JIR.S268262","article-title":"Indeterminate colitis \u2013 update on treatment options","volume":"14","author":"Venkateswaran","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0370","unstructured":"MdSyP. S. \u00bfqu\u00e9 es sispro? [cited 2024 Mar 15]. Available from: https:\/\/www.sispro.gov.co\/Pages\/Home.aspx."},{"key":"10.1016\/j.gastrohep.2025.502532_bib0375","series-title":"Python 3 reference manual","author":"Van Rossum","year":"2009"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0380","series-title":"Python reference manual","author":"Van Rossum","year":"1995"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0385","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125620","article-title":"The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) statement: methods for arriving at consensus and developing reporting guidelines","volume":"10","author":"Nicholls","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0395","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.3748\/wjg.v25.i47.6866","article-title":"Epidemiology of inflammatory bowel disease in South America: a systematic review","volume":"25","author":"Selvaratnam","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0400","article-title":"Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: a large population-based study","volume":"13","author":"Quaresma","year":"2022","journal-title":"Lancet Reg Heal Am"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0405","series-title":"COVID-19 in Latin America and the Caribbean: an overview of government responses to the crisis. OECD policy responses to coronavirus (COVID-19)","year":"2020"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0410","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/medicina58050562","article-title":"Impact of COVID-19 pandemic on the quality of life of IBD patients","volume":"58","author":"Gavrilescu","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0415","first-page":"261","article-title":"Care of inflammatory bowel disease patients in remission","volume":"4","author":"Subramanian","year":"2016","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jcag\/gwy060","article-title":"Integrated care models: optimizing adult ambulatory care in inflammatory bowel disease","volume":"3","author":"Schoenfeld","year":"2020","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0425","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jgh3.12235","article-title":"Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: a systematic review","volume":"4","author":"Prasad","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0430","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/fampra\/cmab006","article-title":"Access to inflammatory bowel disease speciality care: the primary healthcare physician perspective","volume":"38","author":"Burns","year":"2021","journal-title":"Fam Pract"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0435","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00365521.2020.1726445","article-title":"Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015","volume":"55","author":"Alulis","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0440","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/jim-2022-002486","article-title":"Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011\u20132020","volume":"70","author":"Xu","year":"2022","journal-title":"J Investig Med"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0445","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.gastrohep.2023.10.003","article-title":"Experiencia colombiana con el uso de tofacitinib en colitis ulcerosa aguda grave: estudio de serie de casos","volume":"47","author":"Parra-Izquierdo","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0450","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastrohep.2022.10.020","article-title":"Tofacitinib en el tratamiento de la colitis ulcerosa moderada a grave en Colombia: experiencia en mundo real","volume":"46","author":"Parra-Izquierdo","year":"2023","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0455","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.gastrohep.2023.09.013","article-title":"Tofacitinib en el tratamiento de la colitis ulcerosa moderada a grave en pacientes pedi\u00e1tricos colombianos: experiencia en mundo real","volume":"47","author":"Parra-Izquierdo","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0460","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1089099","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0465","first-page":"1102","article-title":"The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia","volume":"23","author":"AlRuthia","year":"2020","journal-title":"J M\u00e9d Econ"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0470","doi-asserted-by":"crossref","first-page":"e0185500","DOI":"10.1371\/journal.pone.0185500","article-title":"A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease","volume":"12","author":"Pillai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0475","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MIB.0000000000000271","article-title":"Impact of drug therapy and surgery on quality of life in Crohn\u02bcs disease: a systematic review","volume":"21","author":"Wright","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn's & Colitis Foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: results from the COIN study","volume":"63","author":"van der Valk","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0490","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.16445","article-title":"Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents","volume":"54","author":"van Linschoten","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0495","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.14309\/00000434-201802001-00034","article-title":"Prevalence of Crohn's disease and ulcerative colitis in Colombia: analysis of the integral information system of social protection (SISPRO): P-034","volume":"113","author":"Juliao-Ba\u00f1os","year":"2018","journal-title":"Am Coll Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0500","first-page":"85","article-title":"Sistemas de informaci\u00f3n en el sector salud en Colombia","volume":"10","author":"Bernal-Acevedo","year":"2011","journal-title":"Rev Gerenc Pol\u00edt Salud"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0505","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008424","article-title":"Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review","volume":"5","author":"van Mourik","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0510","doi-asserted-by":"crossref","first-page":"187","DOI":"10.22379\/24224022426","article-title":"Sispro: La base de datos administrativa del sistema de salud colombiano","volume":"38","author":"Rosselli","year":"2022","journal-title":"Acta Neurol Colomb"},{"key":"10.1016\/j.gastrohep.2025.502532_bib0515","first-page":"107","article-title":"Prevalencia y caracter\u00edsticas demogr\u00e1ficas de la enfermedad inflamatoria intestinal en Cartagena, Colombia","volume":"25","author":"Yepes Barreto","year":"2010","journal-title":"Rev Colomb Gastroenterol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525004029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525004029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T12:23:18Z","timestamp":1767356598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525004029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0210570525004029"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502532","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and healthcare resource utilization in inflammatory bowel disease in Colombia between 2017 and 2021: A retrospective claims database study","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502532"}}